U.S. Dialysis Market - By Type (Hemodialysis, Peritoneal Dialysis), By Product & Service (Equipment, Consumables, Services), By End-use (In-center Dialysis, Home Dialysis) & Global Forecast, 2023-2032

U.S. Dialysis Market Size

U.S. Dialysis Market size was valued at more than USD 42 billion in 2022 and is poised to project nearly 4% CAGR from 2023 to 2032. Surge in the prevalence of end-stage renal failure patients worldwide is fueling industry expansion.

The rising number of end-stage renal disease (ESRD) patients across the U.S. will drive market expansion. ESRD is the terminal stage of chronic kidney disease (CKD), where kidney function declines to an extent where it is no longer possible for it to operate normally. The prevalence of ESRD cases is on the rise across the United States which is forcing patients with kidney failure to consider kidney transplants or dialysis.
 

High incidence of hypertension and blood pressure issues, and an expanding elderly population will drive the need for dialysis in the U.S. The geriatric population of the country aged 60 years and above is projected to be more prone to renal failures or kidney-related issues. Such as scenario will bolster the market growth.
 

Increasing concerns related to product recalls are expected to hamper the expansion of the U.S. dialysis market. Defects in hospital consumables and dialysis equipment have led to recalls that have slowed down industry development. Some issues like internal leaks in the dialysis apparatus during hemodialysis can cause cross-contamination between the catheters recirculating newly filtered blood which makes manufacturers recall their products. For instance, in January 2023, the union SEIU-United Healthcare Workers West requested the FDA to retract some Fresenius dialysis machines to protect patient safety.
 

U.S. Dialysis Market Analysis

U.S. dialysis market share from the hemodialysis segment is expected to surpass USD 54.5 billion by 2032 as it assists in the mineral balancing of calcium, sodium, and potassium, which lowers blood pressure. An increase in the demand for hemodialysis is attributed to the growing number of kidney-related illnesses. Moreover, diabetic patients have a significant risk of having renal conditions that require dialysis at either an acute or chronic stage. According to CDC estimates for 2022, more than 37.3 million people, or 11.3% of the U.S. population, have diabetes and that number will likely rise in the coming years.
 

U.S. dialysis market share from the services segment is anticipated to cross USD 47.5 billion by 2032. The growing accessibility of dialysis at homes and clinics has led to an increase in demand for such services among the patient population. The need for medical supplies used during dialysis is expected to increase as many people opt for this therapy. Many manufacturers in the industry are focusing on creating cutting-edge dialysis equipment that will support the overall industry development.
 

U.S. dialysis market from the in-center dialysis segment is predicted to witness a 3.9% CAGR from 2023 to 2032. Patients operated across these centers have the benefit to relax and interact with other patients and staff, which enhances the effectiveness of their treatment and their general health. The availability of trained renal care professionals offering the best service possible is another factor contributing to the growing popularity of in-center dialysis therapy. Furthermore, the treatment and patient assessment is performed at the same location which increases its adoption, thus proving beneficial for segment value.
 

U.S. dialysis market from the South Atlantic zone is forecasted to reach around USD 13.4 billion by 2032 owing to the high prevalence of chronic diseases, rising per capita income, and aging population in the region. Georgia is home to a vast patient base with chronic renal disorders, which is anticipated to drive market expansion. As per CDC data, in 2021, more than 4% of adults in Georgia were detected with kidney diseases by healthcare professionals.
 

Several market participants ae looking to initiate number of programs to enhance the care of dialysis patients. For instance, in 2021, WellCare Georgia announced its plan to partner with Somatus Inc. to create a care program for patients suffering from end-stage renal disease and CKD. Such initiatives, which aim to aid renal disease patients, will promote the expansion of the industry.
 

U.S. Dialysis Market Share

• Nipro Corporation
• Asahi Kasei Corporation
• U.S. Renal Care, Inc.
• B. Braun Melsungen AG, DaVita Inc.
• Becto
• Dickinson and Company
• Medtronic plc
• Fresenius Medical Care AG & Co.
• American Renal Associates
• Sanderling Renal Services
• Toray Industries Inc.
• Baxter International Inc.

are among the prominent solution providers of the U.S. dialysis market.
 

In 2021, DaVita launched virtual support groups through DaVita Care Connect, a mobile health platform created especially for those receiving home dialysis. This virtual assistance system aimed to let the company connect with several patients who are receiving treatment at home while growing its consumer base.  
 

Impact of COVID-19 Pandemic

The COVID-19 pandemic had a marginal impact on the U.S. dialysis industry. Most individuals were seeking diagnosis and treatment in homecare facilities in order to provide the best possible care during the pandemic. Some of the manufacturers in the market increased the production of essentials and supplies to boost their productivity. For instance, Baxter doubled the production of the fluids and equipment needed for the dialysis process. Increasing cases of ESRD and kidney disorders will bolster the U.S market in the post COVID-19 era.
 

U.S. dialysis market research report includes in-depth coverage of the industry with estimates & forecasts in terms of revenue in USD from 2018 to 2032, for the following segments:

Click here to Buy Section of this Report

By Type

• Hemodialysis 
• Peritoneal Dialysis

By Product and Services

• Equipment
  • Dialysis Machines
  • Water Treatment Systems
  • Others
• Consumables
  • Dialyzers
  • Catheters
  • Access Products
  • Concentrates
  • Others
• Services
  • Acute dialysis
  • Chronic dialysis

By End-use

• In-center Dialysis
• Home Dialysis

The above information is provided for the following zones:

• East North Central
  • Illinois
  • Indiana
  • Michigan
  • Ohio
  • Wisconsin
• West South Central
  • Arkansas
  • Louisiana
  • Oklahoma
  • Texas
• South Atlantic
  • Delaware
  • Florida
  • Georgia
  • Maryland
  • North Carolina
  • South Carolina
  • Virginia
  • West Virginia
  • Washington, D.C.
• North East
  • Connecticut
  • Maine
  • Massachusetts
  • New Hampshire
  • Rhode Island
  • Vermont
  • New Jersey
  • New York
  • Pennsylvania
• East South Central
  • Alabama
  • Kentucky
  • Mississippi
  • Tennessee
• West North Central
  • Iowa
  • Kansas
  • Minnesota
  • Missouri
  • Nebraska
  • North Dakota
  • South Dakota
• Pacific Central
  • Alaska
  • California
  • Hawaii
  • Oregon
  • Washington
• Mountain States
  • Arizona
  • Colorado
  • Utah
  • Nevada
  • New Mexico
  • Idaho
  • Montana
  • Wyoming